US Stock MarketDetailed Quotes

ANIP ANI Pharmaceuticals

Watchlist
  • 56.010
  • -2.180-3.75%
Close Nov 4 16:00 ET
1.18BMarket Cap47.07P/E (TTM)

ANI Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ANI Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 8, 2024

Estimate YoY
Revenue
144.37M
+9.52%
EPS
-<0.01
-100.71%
Analyst Rating
Strong Buy

Oct 31, 2024

ANI Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 170.519M--
Nov 8, 20242024/Q3-- / 144.375M--
Aug 6, 20242024/Q2138.040M / 129.053M--
May 10, 20242024/Q1137.430M / 126.028M--
Feb 29, 20242023/Q4131.654M / 124.935M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 170.519M--
Nov 8, 20242024/Q3-- / 144.375M--
Aug 6, 20242024/Q2138.040M / 129.053M--
May 10, 20242024/Q1137.430M / 126.028M--
Feb 29, 20242023/Q4131.654M / 124.935M--

Unlock Free Earnings Estimates

ANI Pharmaceuticals Earnings Reports

  • ANI Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 07:03 ET

  • ANI Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 10 07:13 ET

  • ANI Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 29 07:28 ET

  • ANI Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 07:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data